Invesco Dynamic Pharmaceuticals ETF (PJP)

78.01
Delayed Data
As of Nov 29
 -0.70 / -0.89%
Today’s Change
66.60
Today|||52-Week Range
83.23
+9.26%
Year-to-Date

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Performance

1 month-0.01% 3 years+6.09%
3 months-2.54% 5 years+7.42%
1 year+18.71% Since inception+12.05%
Data through 11/27/2021

Quote Details

Previous close$78.71
Open day’s range77.96 – 78.69
Net asset value (NAV)78.75 (11/26/2021)
Daily volume32,962
Average volume (3 months)19,522
Data as of 3:59pm ET, 11/29/2021

Peer Comparisonvs. Health ETFs

 PJPCategory
Performance 5-yr return+7.42%+13.75%
Expense Gross exp ratio0.58%1.00%
Risk 5 year sharpe ratio0.470.91
Net assets$433.1M$2.4B
Average market cap$32.0B$37.7B
Average P/E21.925.0
Dividend / Share--0.29%

Competitors

RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MRK Merck6.99%
ABT Abbott Laboratories6.34%
LLY Eli Lilly and Co5.98%
ABBV AbbVie5.91%
JNJ Johnson & Johnson5.73%
AMGN Amgen5.69%
PFE Pfizer5.58%
GILD Gilead Sciences5.54%
LGND Ligand Pharmaceuticals Inc4.84%
SUPN Supernus Pharmaceuticals Inc4.55%